BioSmart Co.,Ltd. Statistics

Total Valuation

BioSmart Co.,Ltd. has a market cap or net worth of KRW 88.26 billion. The enterprise value is 173.05 billion.

Market Cap	88.26B
Enterprise Value	173.05B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

BioSmart Co.,Ltd. has 23.04 million shares outstanding. The number of shares has decreased by -8.42% in one year.

Shares Outstanding	23.04M
Shares Change (YoY)	-8.42%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	20.89%
Owned by Institutions (%)	0.96%
Float	17.96M

Valuation Ratios

The trailing PE ratio is 14.29.

PE Ratio	14.29
Forward PE	n/a
PS Ratio	0.17
PB Ratio	0.74
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.85, with an EV/FCF ratio of -10.29.

EV / Earnings	19.31
EV / Sales	0.37
EV / EBITDA	8.85
EV / EBIT	15.13
EV / FCF	-10.29

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.57.

Current Ratio	1.46
Quick Ratio	0.27
Debt / Equity	0.57
Debt / EBITDA	4.64
Debt / FCF	-4.97
Interest Coverage	1.70

Financial Efficiency

Return on equity (ROE) is 6.85% and return on invested capital (ROIC) is 2.97%.

Return on Equity (ROE)	6.85%
Return on Assets (ROA)	2.40%
Return on Capital (ROIC)	2.97%
Revenue Per Employee	2.91B
Profits Per Employee	54.97M
Employee Count	163
Asset Turnover	1.84
Inventory Turnover	7.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.49% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+17.49%
50-Day Moving Average	3,883.50
200-Day Moving Average	4,082.50
Relative Strength Index (RSI)	56.87
Average Volume (20 Days)	113,239

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioSmart Co.,Ltd. had revenue of KRW 473.76 billion and earned 8.96 billion in profits. Earnings per share was 267.96.

Revenue	473.76B
Gross Profit	73.33B
Operating Income	9.88B
Pretax Income	14.77B
Net Income	8.96B
EBITDA	18.01B
EBIT	9.88B
Earnings Per Share (EPS)	267.96

Full Income Statement

Balance Sheet

The company has 27.52 billion in cash and 83.52 billion in debt, giving a net cash position of -56.00 billion or -2,430.36 per share.

Cash & Cash Equivalents	27.52B
Total Debt	83.52B
Net Cash	-56.00B
Net Cash Per Share	-2,430.36
Equity (Book Value)	146.34B
Book Value Per Share	5,156.91
Working Capital	47.89B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.59 billion and capital expenditures -4.22 billion, giving a free cash flow of -16.82 billion.

Operating Cash Flow	-12.59B
Capital Expenditures	-4.22B
Free Cash Flow	-16.82B
FCF Per Share	-729.86

Full Cash Flow Statement

Margins

Gross margin is 15.48%, with operating and profit margins of 2.09% and 1.89%.

Gross Margin	15.48%
Operating Margin	2.09%
Pretax Margin	3.12%
Profit Margin	1.89%
EBITDA Margin	3.80%
EBIT Margin	2.09%
FCF Margin	-3.55%

Dividends & Yields

BioSmart Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	8.42%
Shareholder Yield	8.42%
Earnings Yield	7.00%
FCF Yield	-19.06%

Stock Splits

The last stock split was on September 20, 2010. It was a reverse split with a ratio of 0.16667.

Last Split Date	Sep 20, 2010
Split Type	Reverse
Split Ratio	0.16667

Scores

BioSmart Co.,Ltd. has an Altman Z-Score of 2.64. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.64
Piotroski F-Score	n/a